Resveratrol: A Clinician Point of View

Gulec S.

TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, cilt.33, sa.3, ss.122-125, 2008 (SCI-Expanded, TRDizin) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Sayı: 3
  • Basım Tarihi: 2008
  • Dergi Adı: TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.122-125
  • Anahtar Kelimeler: Resveratrol, evidence based medicine, randomized clinical trial, CORONARY-HEART-DISEASE, VITAMIN-E, HOMOCYSTEINE, DEATH, RISK
  • Ankara Üniversitesi Adresli: Evet

Özet

Experimental data suggest that resveratrol, an antioxidant molecule, has beneficial effects on cardiovascular system. Evidence-based medicine (EBM) aims to apply evidence gained from the hard end-point placebo controlled randomized clinical trials to certain parts of medical practice. There have been many molecules, including vitamin E, which were shown to have positive effects in experimental models (that is further supported by observational clinical studies) but failed to show any benefit in hard end-point randomized clinical trials.